Chewy's Path to $100: A Realistic Look at the Pet Retailer's Ascent

Chewy, Inc. (NYSE: CHWY), once a quintessential pandemic-era winner, faces a critical juncture. The online pet specialty retailer, which saw its shares soar past $120 during the lockdown-fueled e-commerce boom, is now building a more sustainable growth model beyond those exceptional times. The question on many investors' minds: Can this journey eventually propel the stock back to the coveted $100 mark?

The company's initial success was built on a powerful combination: competitive pricing and a fanatical focus on customer service that larger rivals often neglect. This carved out a loyal niche in the massive pet care market. However, as physical stores reopened, Chewy's growth trajectory inevitably normalized, leading to a significant stock correction.

Undeterred, management has strategically pivoted. The expansion into pet pharmacy and telehealth services represents a crucial move beyond low-margin retail. These verticals offer higher profitability and deepen customer relationships. The financials reflect this transition: For the first three quarters of fiscal 2025, net sales climbed 8% year-over-year to over $9.3 billion, with operating income surging an impressive 74% as cost controls took hold.

Yet, challenges persist. A one-time income tax benefit in the prior year created a tough comparison, pulling the net margin down to 2% for the recent period from 4.3%. Furthermore, Chewy remains susceptible to broader consumer spending pressures, a factor that contributed to its stock weakness over the past year.

The valuation tells a story of tempered expectations. While the current P/E ratio appears steep at 55, the forward P/E of approximately 17 suggests analysts see significant earnings growth ahead. This more reasonable multiple could attract value-oriented investors who had previously steered clear.

Analyst Perspective: "Chewy is executing well in a defensive sector," says Marcus Thorne, a portfolio manager at Cedar Rock Capital. "The shift to healthcare services is the right long-term play. At a forward P/E of 17, the risk-reward profile is intriguing, but investors should view this as a steady compounder, not a hyper-growth story."

Bullish Take: Rebecca Choi, an independent retail analyst, is more optimistic: "The market is massively underestimating the lifetime value of a Chewy customer. Once you use their pharmacy or talk to their vet, you're locked into their ecosystem. This isn't just about selling dog food; it's about owning the pet parent relationship. $100 is a question of 'when,' not 'if.'"

Critical View: David Keller, a vocal financial blogger, offers a sharp counterpoint: "This is a classic 'hope trade.' Single-digit revenue growth in a brutally competitive, low-margin business does not justify a march to $100. They're trying to be Amazon, CVS, and Teladoc for pets all at once. That's a fantastic way to burn capital and dilute focus. The forward P/E looks cheap only if you ignore the structural headwinds of pure-play e-commerce."

Verdict: Chewy has successfully evolved from a pandemic beneficiary to a more diversified pet care platform. Its improving profitability and strategic expansions merit a re-rating. While the stock appears positioned for gradual appreciation and could potentially outperform the broader market, the leap to $100 per share would require a dramatic acceleration in growth or a significant expansion of its profit margins—neither of which is currently in the forecast. For now, Chewy represents a promising, if patient, bet on the resilient pet economy, not a short-term rocket ship.

Disclosure: The author has no position in CHWY. This analysis is for informational purposes only and should not be considered financial advice.